Youngson Kim

Youngson Kim possesses extensive experience in quality assurance and quality control within the pharmaceutical industry, currently serving as Director of Commercial Product QCQA at Mirum Pharmaceuticals, Inc. since August 2021. Previous roles include Associate Director of Quality Assurance at Corcept Therapeutics and Sr. QA Manager at Versartis, along with various positions at Lantheus Medical Imaging, AstraZeneca, and other organizations. Kim's expertise encompasses drug substance validation, analytical method development, regulatory submissions, and quality oversight across multiple contract manufacturing organizations. With a Bachelor’s degree in Chemistry from the University of Massachusetts Dartmouth, Kim is well-equipped in providing guidance on quality systems, compliance, and laboratory analytics throughout the drug development lifecycle.